Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis
- 16 June 2007
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 70 (1) , 66-69
- https://doi.org/10.1016/j.mehy.2007.04.030
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006
- Epidemic influenza and vitamin DEpidemiology and Infection, 2006
- Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosisBrain, 2006
- 1,25 dihydroxyvitamin‐D3 modulates JAK–STAT pathway in IL‐12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitisJournal of Neuroscience Research, 2006
- Manipulating dendritic cells to induce regulatory T cellsMicrobes and Infection, 2005
- Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control studyBMJ, 2003
- Epstein-Barr Virus Transactivates the Human Endogenous Retrovirus HERV-K18 that Encodes a SuperantigenImmunity, 2001
- 1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cellsMolecular Immunology, 1989
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983